{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":48,"n_cols":5,"rows_kept":48,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[24,2,24,3],[25,2,25,3],[28,2,28,3],[28,4,28,5],[29,2,29,3],[29,4,29,5],[30,2,30,3],[30,4,30,5],[31,2,31,3],[32,2,32,3],[34,2,34,3],[35,2,35,3],[36,2,36,3],[37,2,37,3],[38,2,38,3],[42,2,42,3],[43,2,43,3],[45,2,45,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA996217126503316"]
[null,null,"Titolo",null,"Thin-layer chromatographic Rf values of toxicologically relevant substances on standardized systems"]
[null,null,"Pubbl/distr/stampa",null,"[Place of publication not identified], : VCH, 1992"]
[null,null,"ISBN",null,"3-527-60925-3"]
[null,null,"Collana",null,"Report 17 of the DFG Commission for Clinical-Toxicological Analysis Thin-layer chromatographic Rf values of toxicologically relevant substances on standardized systems"]
[null,null,"Disciplina",null,"615.9/07"]
[null,null,"Soggetti",null,"Poisons - Tables - Analysis"]
[{"$nulls":4},"Rf values (Chromatography) - Tables"]
[{"$nulls":4},"Thin layer chromatography - Tables"]
[{"$nulls":4},"Analytical toxicology - Tables"]
[{"$nulls":4},"Chromatography, Thin Layer"]
[{"$nulls":4},"Pharmaceutical Preparations"]
[{"$nulls":4},"Poisons"]
[{"$nulls":4},"Noxae"]
[{"$nulls":4},"Specialty Uses of Chemicals"]
[{"$nulls":4},"Chromatography, Liquid"]
[{"$nulls":4},"Toxic Actions"]
[{"$nulls":4},"Chromatography"]
[{"$nulls":4},"Chemical Actions and Uses"]
[{"$nulls":4},"Chemistry Techniques, Analytical"]
[{"$nulls":4},"Investigative Techniques"]
[{"$nulls":4},"Toxicology & Public Health"]
[{"$nulls":4},"Public Health"]
[{"$nulls":4},"Health & Biological Sciences"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,"2.","Record Nr.",null,"UNINA9910350241403321"]
[null,null,"Autore",null,"Blank Robert H"]
[null,null,"Titolo",null,"Social & Public Policy of Alzheimer's Disease in the United States / / by Robert H. Blank"]
[null,null,"Pubbl/distr/stampa",null,"Singapore : , : Springer Nature Singapore : , : Imprint : Palgrave Pivot, , 2019"]
[null,null,"ISBN",null,"9789811306563"]
[{"$nulls":4},"9811306567"]
[null,null,"Edizione",null,"[1st ed. 2019.]"]
[null,null,"Descrizione fisica",null,"1 online resource (XI, 171 p.)"]
[null,null,"Collana",null,"Palgrave pivot"]
[null,null,"Disciplina",null,"320.6"]
[null,null,"Soggetti",null,"Political planning"]
[{"$nulls":4},"Public health administration"]
[{"$nulls":4},"Public Policy"]
[{"$nulls":4},"Health Administration"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"1. Alzheimer's Disease and Other Dementias: An Introduction -- 2. Public Policy Context: Funding and Policy Initiatives -- 3. The Alzheimer's Marketplace -- 4. Caregivers, Long Term Care and Social Health -- 5. Public Health Approaches to Alzheimer's Disease -- 6. End-of-Life Decision Making for Alzheimer's Disease across Cultures -- 7. Alzheimer's Policy: Future Directions. ."]
[null,null,null,"Sommario/riassunto","This book focuses on the public policy and political dimensions of Alzheimer's Disease and other dementias (AD/D) in the United States, with coverage of the global dimensions and relevant examples from other countries. Starting off with a discussion on the characteristics of AD/D and competing theories of their causes, their human and financial costs, and the increasing burden they place on all societies as populations age, the book examines in detail the range of policy issues they raise. These include funding policies, payment policy and regulatory functions, long-term services and support (LTCS), public health and prevention policies. The book analyses the big business surrounding AD/D and shows that the strong public fear of developing dementia heightens the likelihood of exploitation of vulnerable people looking for a technological fix. It examines both informal and formal caregivers and the heavy burden placed on families, primarily women, and recent policy attempts to strengthen LTCS. It also examines the "]
[{"$nulls":4},"latest evidence of potential risk-reduction and prevention strategies and the difficult issues surrounding advance directives, assisted suicide, and definitions of death that increasingly face policy makers. It concludes by analyzing the policy implications on possible technological scenarios. Robert H. Blank, PhD, (University of Maryland) is an adjunct Professor of Political Science at the University of Canterbury in Christchurch, New Zealand, and a research scholar at New College Florida. He has been a frequent guest professor at Aarhus University in Denmark and at National Taiwan University in Taipei, Taiwan. ."]